ArticleExperimental hematology & oncology2022

Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model.

Xue-Feng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.